Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Kwak

Concepts (172)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fluorodeoxyglucose F18
11
2024
164
1.340
Why?
Positron-Emission Tomography
13
2024
343
1.330
Why?
Sentinel Lymph Node
5
2019
49
1.090
Why?
Sentinel Lymph Node Biopsy
6
2019
118
1.040
Why?
Melanoma
9
2024
765
0.960
Why?
Head and Neck Neoplasms
5
2019
563
0.770
Why?
Skin Neoplasms
6
2019
806
0.760
Why?
Fever of Unknown Origin
1
2023
13
0.760
Why?
Multimodal Imaging
6
2016
137
0.740
Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
15
0.740
Why?
Radiopharmaceuticals
11
2024
210
0.720
Why?
Lung Neoplasms
10
2025
2675
0.650
Why?
Thyroid Neoplasms
3
2020
380
0.650
Why?
Lymphoscintigraphy
2
2019
10
0.640
Why?
Graves Disease
1
2020
32
0.640
Why?
Four-Dimensional Computed Tomography
5
2025
38
0.600
Why?
Spirituality
1
2020
88
0.570
Why?
Positron Emission Tomography Computed Tomography
6
2024
122
0.550
Why?
Chemoradiotherapy, Adjuvant
2
2016
44
0.500
Why?
Iodine Radioisotopes
4
2020
139
0.450
Why?
Hamartoma
1
2015
29
0.420
Why?
Rectal Neoplasms
1
2016
160
0.420
Why?
Radiotherapy Planning, Computer-Assisted
4
2025
150
0.410
Why?
Tomography, X-Ray Computed
7
2016
2786
0.400
Why?
Diagnostic Imaging
1
2015
340
0.350
Why?
Lymphoma
2
2026
251
0.310
Why?
Radiation Pneumonitis
2
2021
31
0.310
Why?
Immunotherapy
1
2015
671
0.300
Why?
Neoplasm Recurrence, Local
4
2020
1160
0.290
Why?
Adenocarcinoma
1
2016
927
0.280
Why?
Lung
5
2023
4122
0.280
Why?
Chemoradiotherapy
2
2020
238
0.260
Why?
Neuroendocrine Tumors
2
2022
122
0.260
Why?
Lymph Node Excision
2
2019
174
0.250
Why?
Respiratory-Gated Imaging Techniques
2
2016
10
0.240
Why?
Tomography, Emission-Computed, Single-Photon
4
2023
104
0.220
Why?
Radioisotopes
3
2024
37
0.220
Why?
alpha-MSH
1
2024
6
0.210
Why?
Lutetium
1
2024
5
0.210
Why?
Humans
36
2026
146342
0.200
Why?
Ibuprofen
1
2024
87
0.200
Why?
Computer Simulation
2
2026
1014
0.190
Why?
Lymphatic Metastasis
3
2019
335
0.190
Why?
Esophageal Neoplasms
2
2018
351
0.190
Why?
Medical Oncology
1
2026
345
0.180
Why?
Radiotherapy, Intensity-Modulated
2
2025
143
0.180
Why?
Precision Medicine
1
2026
462
0.170
Why?
Aged
14
2025
26432
0.170
Why?
Methimazole
1
2020
5
0.160
Why?
Antithyroid Agents
1
2020
12
0.160
Why?
Retrospective Studies
10
2022
17438
0.160
Why?
Image Processing, Computer-Assisted
1
2025
778
0.160
Why?
Machine Learning
1
2026
594
0.150
Why?
Image-Guided Biopsy
1
2019
41
0.150
Why?
Religion
1
2020
64
0.150
Why?
Nuclear Medicine
1
2019
9
0.150
Why?
Treatment Failure
1
2020
361
0.150
Why?
Scalp
1
2019
38
0.150
Why?
Middle Aged
15
2025
36619
0.150
Why?
Radionuclide Imaging
1
2019
116
0.150
Why?
Neoplasms
1
2015
2954
0.140
Why?
Thyroid Gland
1
2019
93
0.140
Why?
Skin Pigmentation
1
2019
44
0.140
Why?
Aged, 80 and over
8
2020
8391
0.140
Why?
Attitude
1
2020
253
0.140
Why?
Lymphoma, Mantle-Cell
1
2018
36
0.130
Why?
Male
19
2025
73396
0.130
Why?
Prognosis
5
2019
4351
0.130
Why?
ROC Curve
2
2018
617
0.130
Why?
Radiotherapy
1
2018
209
0.130
Why?
Tretinoin
1
2018
115
0.130
Why?
Image Interpretation, Computer-Assisted
2
2016
295
0.120
Why?
Mediastinal Neoplasms
1
2017
54
0.120
Why?
Lymph Nodes
1
2019
511
0.120
Why?
Bone Marrow
1
2018
310
0.120
Why?
Software Validation
1
2016
9
0.120
Why?
Female
19
2025
79499
0.120
Why?
Solitary Pulmonary Nodule
1
2016
25
0.120
Why?
Neoadjuvant Therapy
2
2016
475
0.120
Why?
Lung Diseases
1
2023
787
0.120
Why?
Pulmonary Ventilation
3
2021
80
0.120
Why?
MAP Kinase Kinase Kinases
1
2016
70
0.110
Why?
Dacarbazine
1
2015
98
0.110
Why?
Octreotide
1
2015
23
0.110
Why?
Area Under Curve
1
2016
335
0.110
Why?
Disease-Free Survival
4
2019
778
0.110
Why?
Programmed Cell Death 1 Receptor
1
2017
268
0.110
Why?
Phenylurea Compounds
1
2015
122
0.110
Why?
Societies, Medical
1
2019
907
0.110
Why?
Carcinoma, Papillary, Follicular
1
2014
8
0.110
Why?
Quinolines
1
2015
191
0.100
Why?
Organometallic Compounds
1
2015
110
0.100
Why?
Glycolysis
1
2016
342
0.100
Why?
Proto-Oncogene Proteins B-raf
1
2016
231
0.100
Why?
Kaplan-Meier Estimate
1
2016
970
0.100
Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1195
0.090
Why?
Case-Control Studies
1
2020
3647
0.090
Why?
Adult
9
2020
41087
0.090
Why?
Carcinoma
1
2014
225
0.090
Why?
Treatment Outcome
3
2016
11821
0.090
Why?
Imaging, Three-Dimensional
1
2016
582
0.090
Why?
Survival Rate
4
2019
2092
0.090
Why?
Bone and Bones
1
2015
319
0.090
Why?
Radiotherapy Dosage
2
2025
289
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2016
1998
0.090
Why?
Practice Guidelines as Topic
1
2019
1591
0.080
Why?
Sensitivity and Specificity
1
2016
1998
0.080
Why?
Inflammation
1
2023
2919
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2017
992
0.080
Why?
Carcinoma, Squamous Cell
1
2016
628
0.080
Why?
Perfusion
2
2023
255
0.080
Why?
Antibodies, Monoclonal
1
2017
1512
0.080
Why?
Prostatic Neoplasms
1
2015
972
0.070
Why?
Prospective Studies
4
2023
8123
0.060
Why?
Whole Body Imaging
2
2018
29
0.060
Why?
United States
2
2022
16136
0.060
Why?
Postoperative Complications
1
2019
3034
0.060
Why?
Antineoplastic Agents
1
2017
2219
0.060
Why?
Brain Neoplasms
1
2014
1325
0.050
Why?
Cardiotoxicity
1
2024
35
0.050
Why?
Follow-Up Studies
3
2019
5439
0.050
Why?
Albumins
1
2024
120
0.050
Why?
Melanoma, Experimental
1
2024
106
0.050
Why?
Tissue Distribution
1
2024
334
0.050
Why?
Algorithms
2
2025
1849
0.050
Why?
Magnetic Resonance Imaging
1
2015
3926
0.050
Why?
Receptors, Somatostatin
1
2022
24
0.050
Why?
Child
1
2023
22693
0.050
Why?
Respiration
1
2023
208
0.040
Why?
Immunotherapy, Adoptive
1
2026
356
0.040
Why?
Ligands
1
2022
678
0.040
Why?
Pulmonary Atelectasis
1
2018
15
0.040
Why?
Peptides
1
2024
992
0.030
Why?
Europe
1
2019
421
0.030
Why?
Biological Transport
1
2019
424
0.030
Why?
Thyroglobulin
1
2018
28
0.030
Why?
Observer Variation
1
2018
356
0.030
Why?
Occipital Bone
1
2017
18
0.030
Why?
Parotid Gland
1
2017
17
0.030
Why?
Axilla
1
2017
51
0.030
Why?
Respiratory Function Tests
1
2018
543
0.030
Why?
Survival Analysis
1
2020
1378
0.030
Why?
Neck
1
2017
107
0.030
Why?
Cell Line, Tumor
1
2024
3545
0.030
Why?
Medicare
1
2022
920
0.030
Why?
Response Evaluation Criteria in Solid Tumors
1
2016
21
0.030
Why?
Radiology
1
2018
175
0.030
Why?
Heart
1
2020
626
0.030
Why?
Maximum Tolerated Dose
1
2015
217
0.030
Why?
Fluorouracil
1
2016
231
0.030
Why?
Tumor Burden
1
2016
326
0.030
Why?
Myocardium
1
2020
948
0.030
Why?
Recurrence
1
2017
1133
0.030
Why?
Carcinoma, Papillary
1
2014
83
0.020
Why?
Cisplatin
1
2016
347
0.020
Why?
Neoplasm Metastasis
1
2016
693
0.020
Why?
Mice, Inbred C57BL
1
2024
6034
0.020
Why?
Analysis of Variance
1
2016
1298
0.020
Why?
Preoperative Care
1
2016
396
0.020
Why?
Adolescent
3
2018
22557
0.020
Why?
Research Design
1
2018
1143
0.020
Why?
Biopsy
1
2015
1075
0.020
Why?
Ultrasonography
1
2015
788
0.020
Why?
Dose-Response Relationship, Drug
1
2015
2022
0.020
Why?
Reproducibility of Results
1
2018
3416
0.020
Why?
Predictive Value of Tests
1
2016
2113
0.020
Why?
Young Adult
2
2018
14330
0.020
Why?
Protein Kinase Inhibitors
1
2016
983
0.020
Why?
Cohort Studies
1
2018
6077
0.020
Why?
Mice
1
2024
18297
0.020
Why?
Mutation
1
2016
4093
0.010
Why?
Animals
1
2024
38107
0.010
Why?
Kwak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)